Notice NOT-AG-22-021 from the NIH Guide for Grants and Contracts

Notice NOT-GM-22-035 from the NIH Guide for Grants and Contracts

Notice NOT-NS-22-093 from the NIH Guide for Grants and Contracts

Funding Opportunity RFA-AA-22-001 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites applications for specialized Alcohol Research Centers using the P50 mechanism. The overall purpose of the NIAAA Alcohol Research Center program is to provide leadership in conducting and fostering interdisciplinary, collaborative research on a wide variety of topics relevant to the Institutes mission. These topics include, but are not limited to: the nature, etiology, genetics, diagnosis, treatment, and prevention of alcohol use disorder, alcohol-related end organ diseases and their biomedical, psychosocial, and economic consequences across the lifespan and racial/ethnic groups and other health disparity populations. Centers also are regional or national resources that contribute to the development of new research methods, technologies and approaches that sustain innovative goal-directed research.

Funding Opportunity RFA-AA-22-002 from the NIH Guide for Grants and Contracts. This FOA uses the NIH Comprehensive Research Center (P60) mechanism to support an integrated, broad-based multidisciplinary, multi-investigator, long-term program of research and research support activities planned around a specific major research theme.

Notice NOT-DE-22-008 from the NIH Guide for Grants and Contracts

Research Bioinformatics Analyst: Under direction of investigator, engage in bioinformatic analysis of next generation sequencing (NGS).
From Versiti - Wed, 13 Apr 2022 21:10:50 GMT - View all Wauwatosa, WI jobs

Funding Opportunity RFA-RM-22-018 from the NIH Guide for Grants and Contracts. The NIH Directors Pioneer Award Program supports individual scientists of exceptional creativity who propose highly innovative and potentially transformative research towards the ultimate goal of enhancing human health. For the program to support the best possible researchers and research, applications are sought which reflect the full diversity of the research workforce. Individuals from diverse backgrounds and from the full spectrum of eligible institutions in all geographic locations are strongly encouraged to apply to this Funding Opportunity Announcement. In addition, applications in all topics relevant to the broad mission of NIH are welcome, including, but not limited to, topics in the behavioral, social, biomedical, applied, and formal sciences and topics that may involve basic, translational, or clinical research. To be considered pioneering, the proposed research must reflect substantially different scientific directions from those already being pursued in the investigators research program or elsewhere. The NIH Directors Pioneer Award is a component of the High-Risk, High-Reward Research program of the NIH Common Fund.

Notice NOT-OD-22-111 from the NIH Guide for Grants and Contracts

Notice NOT-NS-22-094 from the NIH Guide for Grants and Contracts

Experience in developing bioinformatics analysis workflows across different types of data (e.g., clinical, cohort, omics). Reports to: Director, Data Science.
From Gates Ventures - Wed, 13 Apr 2022 17:23:50 GMT - View all Kirkland, WA jobs

Notice NOT-NS-22-096 from the NIH Guide for Grants and Contracts

£38,433-£46,039 per annum: Wellcome Sanger Institute: The Opportunity We are seeking a highly motivated Senior Bioinformatiian to join the Translational science team within Dr Teichmann’s lab at the Ce... Cambridgeshire

Funding Opportunity PAR-22-162 from the NIH Guide for Grants and Contracts. Through this Funding Opportunity Announcement (FOA), the National Cancer Institute (NCI) encourages grant applications to support cancer epidemiology research in established cohort studies, defined as studies that have achieved their initial planned recruitment goal. Applications must include hypothesis-based research using data from an established cohort study and are expected to include support for cohort maintenance, continued follow-up, and sharing of the existing resources in addition to addressing research questions across the cancer control continuum.

Funding Opportunity RFA-AI-22-024 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to solicit applications from investigators to enroll large, digitally-maintained cohorts of people with HIV-1 (PWH) in the United States which employ sampling strategies that ensure meaningful enrollment of participants who report prior gaps in HIV care engagement and/or lack of sustained viral suppression (VS). The goal is to follow the research cohort over time to prospectively investigate trajectories of HIV care engagement and viral suppression, as well as the temporal antecedents and multilevel factors that drive changes in care engagement, antiretroviral adherence, and viral suppression. Researchers may test strategies for improved methods of screening, enrollment, and retention of cohort participants. Projects should seek to inform future interventions to promote sustained engagement in HIV care and sustained HIV viral suppression, and additionally have the option of testing digitally-delivered interventions toward that end.

£0 - £50000 per annum: CK Group: Natasha Young is recruiting for a Senior Bioinformatician to join a small, dedicated team providing an outsourced service to one of the top ten largest... Bracknell

£0 - £50000 per annum: CK Group: Natasha Young is recruiting for a Senior Computational Biologist to join a small, dedicated team providing an outsourced service to one of the top ten... Bracknell

Practical experience in one or more of the following areas: differential expression of RNAseq data for multifactor experiments, analysis of single-cell data, or…
From University of Wisconsin–Madison - Tue, 12 Apr 2022 19:21:21 GMT - View all Madison, WI jobs

Funding Opportunity PAR-22-150 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to support an IDeA Clinical Research Resource Center (I-CRRC) that addresses two specific needs for increasing capacity to conducting clinical trials and complex observational studies in IDeA states. I-CRRC will 1) strengthen communication and develop collaborations between health research institutions in IDeA-eligible states and clinical trial sponsors, and 2) develop clinical trial and observational study coordinators with the knowledge and skills to manage clinical studies.

Funding Opportunity PAR-22-149 from the NIH Guide for Grants and Contracts. The NEI uses U01 cooperative agreement awards to support investigator-initiated early-stage clinical trials that are greater than minimal risk and typically are Phase I or II trials. The risk level of the U01 trial requires appropriate performance oversight and safety monitoring. For purposes of this FOA, the proposed study must be intended to evaluate interventions aimed at screening, diagnosing, preventing, or treating vision disorders.